Sartorius Aktiengesellschaft (SUVPF)
USD 224.0
(0.0%)
USD 224.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 9.75 Billion EUR | 39.81% |
| 2022 | 6.97 Billion EUR | 22.46% |
| 2021 | 5.69 Billion EUR | 21.3% |
| 2020 | 4.69 Billion EUR | 65.15% |
| 2019 | 2.84 Billion EUR | 12.56% |
| 2018 | 2.52 Billion EUR | 9.97% |
| 2017 | 2.29 Billion EUR | 31.07% |
| 2016 | 1.75 Billion EUR | 21.97% |
| 2015 | 1.43 Billion EUR | 12.95% |
| 2014 | 1.27 Billion EUR | 8.35% |
| 2013 | 1.17 Billion EUR | 9.65% |
| 2012 | 1.07 Billion EUR | 11.12% |
| 2011 | 963.83 Million EUR | 19.33% |
| 2010 | 807.74 Million EUR | -1.55% |
| 2009 | 820.42 Million EUR | -5.15% |
| 2008 | 865 Million EUR | 10.34% |
| 2007 | 783.93 Million EUR | 107.75% |
| 2006 | 377.34 Million EUR | 2.97% |
| 2005 | 366.44 Million EUR | 2.66% |
| 2004 | 356.95 Million EUR | -2.52% |
| 2003 | 366.19 Million EUR | -8.02% |
| 2002 | 398.13 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 10.62 Billion EUR | 8.94% |
| 2024 Q3 | 9.79 Billion EUR | -1.49% |
| 2024 Q2 | 9.94 Billion EUR | -6.45% |
| 2023 Q2 | 7.04 Billion EUR | 1.12% |
| 2023 Q4 | 9.75 Billion EUR | -2.06% |
| 2023 Q3 | 9.96 Billion EUR | 41.43% |
| 2023 FY | 9.75 Billion EUR | 39.81% |
| 2023 Q1 | 6.96 Billion EUR | -0.19% |
| 2022 Q3 | 7.09 Billion EUR | 13.5% |
| 2022 Q2 | 6.24 Billion EUR | 5.34% |
| 2022 Q4 | 6.97 Billion EUR | -1.6% |
| 2022 Q1 | 5.93 Billion EUR | 4.09% |
| 2022 FY | 6.97 Billion EUR | 22.46% |
| 2021 Q3 | 5.68 Billion EUR | 9.06% |
| 2021 FY | 5.69 Billion EUR | 21.3% |
| 2021 Q2 | 5.21 Billion EUR | 3.05% |
| 2021 Q1 | 5.05 Billion EUR | 7.7% |
| 2021 Q4 | 5.69 Billion EUR | 0.21% |
| 2020 Q3 | 4.15 Billion EUR | 7.87% |
| 2020 FY | 4.69 Billion EUR | 65.15% |
| 2020 Q1 | 2.93 Billion EUR | 3.35% |
| 2020 Q2 | 3.85 Billion EUR | 30.98% |
| 2020 Q4 | 4.69 Billion EUR | 13.1% |
| 2019 FY | 2.84 Billion EUR | 12.56% |
| 2019 Q4 | 2.84 Billion EUR | 0.65% |
| 2019 Q3 | 2.82 Billion EUR | 4.02% |
| 2019 Q2 | 2.71 Billion EUR | 2.16% |
| 2019 Q1 | 2.65 Billion EUR | 5.23% |
| 2018 Q4 | 2.52 Billion EUR | 0.47% |
| 2018 Q2 | 2.41 Billion EUR | 2.74% |
| 2018 FY | 2.52 Billion EUR | 9.97% |
| 2018 Q1 | 2.35 Billion EUR | 2.45% |
| 2018 Q3 | 2.51 Billion EUR | 3.99% |
| 2017 FY | 2.29 Billion EUR | 31.07% |
| 2017 Q1 | 2.27 Billion EUR | 30.04% |
| 2017 Q3 | 2.3 Billion EUR | 0.63% |
| 2017 Q4 | 2.29 Billion EUR | -0.36% |
| 2017 Q2 | 2.29 Billion EUR | 0.53% |
| 2016 Q3 | 1.73 Billion EUR | 3.69% |
| 2016 FY | 1.75 Billion EUR | 21.97% |
| 2016 Q4 | 1.75 Billion EUR | 1.0% |
| 2016 Q2 | 1.67 Billion EUR | 12.27% |
| 2016 Q1 | 1.49 Billion EUR | 3.73% |
| 2015 Q4 | 1.43 Billion EUR | 3.2% |
| 2015 FY | 1.43 Billion EUR | 12.95% |
| 2015 Q1 | 1.3 Billion EUR | 2.9% |
| 2015 Q2 | 1.33 Billion EUR | 1.91% |
| 2015 Q3 | 1.39 Billion EUR | 4.37% |
| 2014 FY | 1.27 Billion EUR | 8.35% |
| 2014 Q3 | 1.24 Billion EUR | 2.77% |
| 2014 Q1 | 1.17 Billion EUR | 0.1% |
| 2014 Q4 | 1.27 Billion EUR | 2.54% |
| 2014 Q2 | 1.2 Billion EUR | 2.71% |
| 2013 Q2 | 1.09 Billion EUR | 0.2% |
| 2013 Q1 | 1.09 Billion EUR | 2.19% |
| 2013 FY | 1.17 Billion EUR | 9.65% |
| 2013 Q4 | 1.17 Billion EUR | 6.11% |
| 2013 Q3 | 1.1 Billion EUR | 0.92% |
| 2012 Q4 | 1.07 Billion EUR | 4.48% |
| 2012 Q3 | 1.02 Billion EUR | 0.55% |
| 2012 FY | 1.07 Billion EUR | 11.12% |
| 2012 Q1 | 1.01 Billion EUR | 5.06% |
| 2012 Q2 | 1.01 Billion EUR | 0.68% |
| 2011 Q4 | 963.83 Million EUR | 11.91% |
| 2011 FY | 963.83 Million EUR | 19.33% |
| 2011 Q2 | 839.1 Million EUR | 2.3% |
| 2011 Q3 | 861.3 Million EUR | 2.65% |
| 2011 Q1 | 820.2 Million EUR | 1.54% |
| 2010 Q4 | 807.74 Million EUR | 0.13% |
| 2010 Q1 | 838 Million EUR | 2.14% |
| 2010 FY | 807.74 Million EUR | -1.55% |
| 2010 Q3 | 806.7 Million EUR | -1.27% |
| 2010 Q2 | 817.1 Million EUR | -2.49% |
| 2009 Q4 | 820.42 Million EUR | 0.0% |
| 2009 FY | 820.42 Million EUR | -5.15% |
| 2008 FY | 865 Million EUR | 10.34% |
| 2007 FY | 783.93 Million EUR | 107.75% |
| 2006 FY | 377.34 Million EUR | 2.97% |
| 2005 FY | 366.44 Million EUR | 2.66% |
| 2004 FY | 356.95 Million EUR | -2.52% |
| 2003 FY | 366.19 Million EUR | -8.02% |
| 2002 FY | 398.13 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -530638.931% |
| Ansell Limited | 3.23 Billion USD | -201.412% |
| Ansell Limited | 3.24 Billion USD | -200.848% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -1894.995% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -3247747.597% |
| Psykey, Inc. | 1.72 Million USD | -564651.991% |
| ConvaTec Group Plc | 3.7 Billion USD | -163.056% |
| ConvaTec Group Plc | 3.71 Billion USD | -162.684% |
| Encision Inc. | 3.81 Million USD | -255896.511% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -1496384.788% |
| LifePoint, Inc. | 8.8 Million USD | -110640.273% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -61038.757% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -1089877.654% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -177623.148% |
| Reflect Scientific, Inc. | 2.66 Million USD | -365417.218% |
| SmileDirectClub, Inc. | 597.06 Million USD | -1533.881% |
| Sector 10, Inc. | 1000.00 USD | -975529900.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | -105.539% |
| SheerVision, Inc. | 837.56 Thousand USD | -1164621.544% |
| United Health Products, Inc. | 284.64 Thousand USD | -3427105.306% |
| Vasamed, Inc. | 1.6 Million USD | -609513.665% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -4371082.894% |
| Yubo International Biotech Limited | 2.34 Million USD | -415275.268% |